ResultsNDTV Profit
Divi's Laboratories Q2 Review: Goldman Sachs, Jefferies, JPMorgan Raise Target Prices; Kotak Maintains Sell
Positive+39Company event
GreyOak summary
Divi's Laboratories reported Q2 revenue up 35% YoY to Rs 3,676 crore and net profit up 64% to Rs 1,127 crore. Goldman Sachs, Jefferies, and JPMorgan raised their target prices citing growth in custom synthesis and GLP-1.
What it affects
- Divi's LaboratoriesDIVISLABPositive +39
Rolling sentiment Positive +80
Source
Read the original at NDTV ProfitMore Divi's Laboratories news
- Buy, Sell Or Hold: Divi's Labs, Tata Power, Kalyan Jewellers, Reliance Industries, L&T And Shriram Finance — Ask ProfitNDTV Profit · Stock view ·
- Scaling up of projects to drive gains for Divi's Labs amid strong Q2 showBusiness Standard · Results ·
- Divi's Market Cap Crosses Rs 3 Lakh CroreNDTV Profit · Company update ·
- Divi's shares jump 4% on 64% profit riseMoneycontrol · Results ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·